Sheikh Khalifa bin Jassim Al Thani (right), Chairman of Qatar Chamber; and Robert Cresanti (left), President and CEO of the International Franchise Association, look on as Abdulaziz bin Nasser Al Khalifa (right, sitting), QDB Chief Executive Officer;and L
DOHA: Qatar and US signed a slew of memoranda of understanding on the sidelines of the ongoing Qatari-US Economic Forum in Washington, DC, in the US.
Minister of Economy and Commerce H E Sheikh Ahmed bin Jassim bin Mohammed Al Thani witnessed the signing of two MoUs between Qatar Development Bank (QDB), and SBDC; and the Venture City.
The first MoU was signed by, QDB Chief Executive Officer Abdul Aziz bin Nasser Al Khalifa,, and President and CEO of SBDC Charles “Tee” Rowe. The MoU aims to share best practices and innovative solutions between the two sides to support small and medium enterprises and to introduce unique and diversified initiatives aimed at assisting Qatari entrepreneurs and qualifying them for the labour market as well as increasing the number of joint research on the growing role played by SMEs in stimulating domestic economic growth, besides assisting in the development and promotion of exports to small and medium enterprises in both countries, and providing access to investment and incubation centers for further cooperation and development.
SBDCs are located in all US states and work in partnership with universities and banks to ensure adequate support for local small businesses by reporting to the US Small Business Administration (SBA).
The US Small Business Commission (SBA) is an independent federal government agency dedicated to providing assistance and advice to small and medium-sized businesses, protecting their interests to maintain competitiveness, and supporting the US economy. The second MoU was signed for QDB by Abdulaziz bin Nasser Al Khalifa, and for The Venture City by Laura Gonzalez-Stefani. The MoU aims to share best practices and innovative solutions between the two parties in the field of investment services to help promote Qatari companies’ exports to the US market, in addition to cooperation in business development and strengthening services for SMEs, and creating a platform for networking between SMEs in Qatar and the United States to share ideas and expertise to enhance the joint cooperation.
The Venture City is a technology ecosystem that supports emerging companies with international potential and invests in early-stage companies with a focus on financial technology and health technology. It also targets artificial intelligence, virtual reality / Enhanced reality technology.
The Venture City has extensive experience in growing technology companies worldwide and supports entrepreneurs not only through financing strategies, but also through engineering, development, marketing, legal and international initiatives.
The Minister of Economy and Commerce also witnessed the signing ceremony of a MoU between ASTAD Company and the leading US airport infrastructure company (AECOM), on the sidelines of the Qatari- US Economic Forum in Washington D.C.
The MoU was signed by the Chief Operating Officer of ASTAD Fahad Al Jahrami and, Director of AECOM Frederick Werner.
The MoU aims at identifying mutual trading opportunities and enhancing joint cooperation in air navigation and infrastructure projects.
Fahad Al Jahrami stressed that the signing of the Memorandum of Understanding (MoU) with AECOM paves the way for joint strategic objectives aimed at directing efforts towards a vital project at the highest levels.
Another MoU was also signed between the Qatari Construction Company and the US company “RoadTech “ in the presence of Sheikh Ahmed.
The MoU was signed by CEO of Qatar Construction Company Bader Mostafawi and Director of RoadTech Jim W. The MoU aims at cooperation between the two companies in the field of road equipment and the exchange of expertise.
The Minister witnessed the signing of a memorandum of understanding between Qatar Pharma and Dawah Pharmaceutical Industries. The MoU was signed by Chairman of the Board of Directors of Qatar Pharma
Pharmaceutical Industries Dr. Ahmed Al Sulaiti, and Founder and CEO of Dawah Dr. Hussam Abdul Maksoud.
The agreement aims to enhance Qatar’s presence in the drug market by taking advantage of FDA-approved medicines and enhancing the country’s pharmaceutical capacity, as well as benefiting from US scientific research in drug development and localization of it in Qatar. Under the MoU, Qatar Pharma will be able to enter international markets, particularly in the United States.
Dr. Ahmed Al Sulaiti, Chairman of Qatar Pharma, said that the signing of the memorandum of understanding with Dawah Pharmaceutical Company is a fruitful start for the two companies. The partnership will help the State of Qatar to create an independent presence in the pharmaceutical market through access to drugs approved by the US Food and Drug Administration, and the ability to produce approved medicines in the future, adding that the new partnership will give Qatar Pharma Pharmaceutical Industries products access to the United States and global markets.
Qatar Pharma is considered one of the most important factories in the pharmaceutical industry in Qatar and seeks to develop high quality products at prices suitable to local and international markets.
The company adopted a new approach to investing in the US economy by encouraging Qatari companies to establish investment partnerships with Small and Medium Enterprises in the United States as well as to increase investments in the healthcare sector in order to provide more job opportunities based on attracting talent and increasing the growth of the local economy, besides contributing to building a positive relationship between the State of Qatar and the United States through the manufacture of generic pharmaceutical products and vital alternatives.
Dawah Pharmaceutical Industries is one of the US companies specialised in the manufacture of sterile medical syringes and needles. The company seeks to meet the needs of international drug markets through the manufacture of products approved by international bodies specialized in this field, including the US Food and Drug Administration (FDA).
The signing ceremony was attended by Chairman of the Qatar Businessmen Association Sheikh Faisal bin Qasim Al Thani, Chairman of Qatar Chamber Sheikh Khalifa bin Jassim Al -Thani, and President and CEO of the International Franchise Association Robert Cresanti, along with a number of businessmen in both countries.
The second MoU was signed for QDB by Abdulaziz bin Nasser Al Khalifa, and for The Venture City by Laura Gonzalez-Stefani.
The MoU aims to share best practices and innovative solutions between the two parties in the field of investment services to help promote Qatari companies’ exports to the US market, in addition to cooperation in business development and strengthening services for SMEs, and creating a platform for networking between SMEs in Qatar and the United States to share ideas and expertise to enhance the joint cooperation.
The Venture City is a technology ecosystem that supports emerging companies with international potential and invests in early-stage companies with a focus on financial technology and health technology. It also targets Artificial Intelligence (AI), Virtual Reality / Enhanced reality technology.
The Venture City has extensive experience in growing technology companies worldwide and supports entrepreneurs not only through financing strategies, but also through engineering, development, marketing, legal and international initiatives.
The Minister of Economy and Commerce also witnessed the signing ceremony of a MoU between ASTAD Company and the leading US airport infrastructure company (AECOM), on the sidelines of the Qatari- US Economic Forum in Washington D.C.
The MoU was signed by the Chief Operating Officer of ASTAD Fahad Al Jahrami and, Director of AECOM Frederick Werner.
Another MoU was also signed between a Qatari construction company and the US company “RoadTech “ in the presence of Sheikh Ahmed.The MoU was signed by CEO of Qatar Construction Company Bader Mostafawi and Director of RoadTech Jim W.
The MoU aims at cooperation between the two companies in the field of road equipment and the exchange of expertise.
The Minister witnessed the signing of a memorandum of understanding between Qatar Pharma and Dawah Pharmaceutical Industries.
The MoU was signed by Chairman of the Board of Directors of Qatar Pharma Pharmaceutical Industries Dr. Ahmed Al Sulaiti, and Founder and CEO of Dawah Dr Hussam Abdul Maksoud.
The agreement aims to enhance Qatar’s presence in the drug market by taking advantage of FDA-approved medicines and enhancing the country’s pharmaceutical capacity, as well as benefiting from US scientific research in drug development and localization of it in Qatar.
Under the MoU, Qatar Pharma will be able to enter international markets, particularly in the United States.
Dr. Ahmed Al Sulaiti, Chairman of Qatar Pharma, said that the signing of the memorandum of understanding with Dawah Pharmaceutical Company is a fruitful start for the two companies. The partnership will help the State of Qatar to create an independent presence in the pharmaceutical market through access to drugs approved by the US Food and Drug Administration, and the ability to produce approved medicines in the future, adding that the new partnership will give Qatar Pharma Pharmaceutical Industries products access to the United States and global markets.
Qatar Pharma is considered one of the most important factories in the pharmaceutical industry in Qatar and seeks to develop high quality products at prices suitable to local and international markets.
The company adopted a new approach to investing in the US economy by encouraging Qatari companies to establish investment partnerships with Small and Medium Enterprises in the United States as well as to increase investments in the healthcare sector in order to provide more job opportunities based on attracting talent and increasing the growth of the local economy, besides contributing to building a positive relationship between the State of Qatar and the United States through the manufacture of generic pharmaceutical products and vital alternatives.
Dawah Pharmaceutical Industries is one of the US companies specialised in the manufacture of sterile medical syringes and needles. The company seeks to meet the needs of international drug markets through the manufacture of products approved by international bodies specialized in this field, including the US Food and Drug Administration (FDA).
The signing ceremony was attended by Chairman of the Qatar Businessmen Association Sheikh Faisal bin Qassim Al Thani, Chairman of Qatar Chamber Sheikh Khalifa bin Jassim Al Thani, and President and CEO of the International Franchise Association Robert Cresanti, along with a number of businessmen in both countries.
